- Home
- INDV
INDV
Indivior PLC
as 12-17-2024 4:00pm EST
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.
| Founded: | 1994 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 1.3B | IPO Year: | N/A |
| Target Price: | $16.00 | AVG Volume (30 days): | 1.1M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.03 | EPS Growth: | N/A |
| 52 Week Low/High: | $7.33 - $23.22 | Next Earning Date: | 10-24-2024 |
| Revenue: | $1,182,000,000 | Revenue Growth: | 13.44% |
| Revenue Growth (this year): | 7.32% | Revenue Growth (next year): | -3.67% |
Latest Indivior PLC News
INDV Breaking Stock News: Dive into INDV Ticker-Specific Updates for Smart Investing
Simply Wall St.
7 days ago
Indivior (LON:INDV) shareholder returns have been enviable, earning 366% in 5 years
GuruFocus.com
25 days ago
Addex Therapeutics Ltd (ADXN) Q3 2024 Earnings Call Highlights: Strategic Partnerships and ...
PR Newswire
a month ago
Rapid Initiation with Once-monthly SUBLOCADE® Superior to Standard Initiation for Treating Opioid Use Disorder, Including in Fentanyl-Positive Patients, According to Data Presented at CSAM 2024
PR Newswire
a month ago
Indivior Responds to Publication of a Letter by Oaktree Capital Management to the Board of Indivior
PR Newswire
2 months ago
Indivior Highlights Growing Body of Data on SUBLOCADE® (buprenorphine once-monthly extended-release injection) Helping Patients Achieve Long-Term Recovery from Opioid Use Disorder during Substance Abuse Prevention Month
GuruFocus.com
2 months ago
Indivior PLC (INDV) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Competitive ...
Zacks
2 months ago
Indivior PLC (INDV) Surpasses Q3 Earnings and Revenue Estimates
PR Newswire
2 months ago
Indivior Announces Q3 2024 Financial Results
Compare INDV vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "INDV Indivior PLC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.